70 related articles for article (PubMed ID: 8029919)
1. Leukocyte inhibition and ex vivo whole blood xenoperfusion.
Henry ML; Bendle MD; Ferguson RM
Transplant Proc; 1994 Jun; 26(3):1311. PubMed ID: 8029919
[No Abstract] [Full Text] [Related]
2. Neutrophils protect xenoendothelium in an ex vivo sequential cell perfusion model.
Henry ML; Bendle MD; Bryan BA; Ferguson RM
Transplant Proc; 1994 Jun; 26(3):1161. PubMed ID: 8029869
[No Abstract] [Full Text] [Related]
3. Neutrophils attenuate thrombus formation in renal xenografts perfused ex vivo.
Bryan BA; Henry ML; Ferguson RM
Transplant Proc; 1992 Apr; 24(2):436. PubMed ID: 1566377
[No Abstract] [Full Text] [Related]
4. Xenoperfusion of pig kidney with human AB or O whole blood.
Otte KE; Andersen N; Jørgensen KA; Kristensen T; Barfort P; Starklint H; Larsen S; Kemp E
Transplant Proc; 1990 Jun; 22(3):1091-2. PubMed ID: 2349669
[No Abstract] [Full Text] [Related]
5. The effect of xenoantibody and formed cellular blood elements on ex vivo xenograft hyperacute rejection.
Han LK; Henry ML; Ferguson RM
Transplant Proc; 1991 Feb; 23(1 Pt 1):574-5. PubMed ID: 1990612
[No Abstract] [Full Text] [Related]
6. Renal xenografts perfused ex vivo require both humoral and cellular components to undergo hyperacute rejection.
Bryan BA; Henry ML; Ferguson RM
Transplant Proc; 1992 Apr; 24(2):609. PubMed ID: 1566449
[No Abstract] [Full Text] [Related]
7. The role of adhesion molecules in human leukocyte attachment to porcine vascular endothelium: implications for xenotransplantation.
Robinson LA; Tu L; Steeber DA; Preis O; Platt JL; Tedder TF
J Immunol; 1998 Dec; 161(12):6931-8. PubMed ID: 9862727
[TBL] [Abstract][Full Text] [Related]
8. Discordant xenogeneic cellular interactions when hyperacute rejection is prevented: analysis using an ex vivo model of pig kidney perfused with human lymphocytes.
Khalfoun B; Janin P; Machet MC; Lacord M; Riess G; Salmon H; Nivet H; Gruel Y; Bardos P; Lebranchu Y
Transplant Proc; 1996 Apr; 28(2):647. PubMed ID: 8623322
[No Abstract] [Full Text] [Related]
9. Ex vivo model for xenotransplantation.
Fiane AE; Videm V; Scholz T; Pedersen T; Karlsen H; Geiran O; Foerster A; Mollnes T; Aasen AO; Svennevig J
Transplant Proc; 1995 Dec; 27(6):3560-1. PubMed ID: 8540102
[No Abstract] [Full Text] [Related]
10. Hyperacute rejection models: ex vivo xenoperfusion systems.
Grinyo JM; Cruzado JM; Torras J
Transplant Proc; 1999; 31(1-2):970-1. PubMed ID: 10083432
[No Abstract] [Full Text] [Related]
11. Xenoperfusion of rabbit kidney and the impact of BN 52021: a specific antagonist of platelet-activating factor.
Otte KE; Jørgensen KA; Bonnevie V; Barfort P; Larsen S; Starklint H; Pirotzky E; Kemp E
Transplant Proc; 1990 Jun; 22(3):1089-90. PubMed ID: 2349668
[No Abstract] [Full Text] [Related]
12. Reduced human neutrophil adhesion to porcine endothelia expressing human decay accelerating factor.
Richards AC; Tucker AW; Carrington CA; White DJ
Transplant Proc; 1996 Apr; 28(2):636. PubMed ID: 8623317
[No Abstract] [Full Text] [Related]
13. Xenograft rejection by dog and man: isolated kidney perfusion with blood and plasma.
Mozes MF; Gewurz H; Gunnarson A; Moberg AW; Westberg NG; Jetzer T; Najarian JS
Transplant Proc; 1971 Mar; 3(1):531-3. PubMed ID: 4937933
[No Abstract] [Full Text] [Related]
14. Potential mechanism of abnormal thromboregulation in xenograft rejection: loss of ecto-ATPases upon endothelial cell activation.
Robson SC; Candinas D; Siegel JB; Kopp C; Millan M; Hancock WW; Bach FH
Transplant Proc; 1996 Apr; 28(2):536. PubMed ID: 8623252
[No Abstract] [Full Text] [Related]
15. Human serum-induced porcine endothelial cell apoptosis--another pathway to xenograft rejection.
Young DS; Kadokura M; Brockhausen I; Kashef V; Coles JG
Transplant Proc; 1996 Apr; 28(2):611-2. PubMed ID: 8623302
[No Abstract] [Full Text] [Related]
16. Ex vivo spleen and kidney absorption of xenoreactive natural antibodies decreases severity of hyperacute rejection in pig-to-dog renal xenotransplantation.
Nitta K
Hiroshima J Med Sci; 1996 Dec; 45(4):119-25. PubMed ID: 9119710
[TBL] [Abstract][Full Text] [Related]
17. Activation of naive xenogeneic but not allogeneic endothelial cells by human naive neutrophils: a potential occult barrier to xenotransplantation.
al-Mohanna F; Collison K; Parhar R; Kwaasi A; Meyer B; Saleh S; Allen S; al-Sedairy S; Stern D; Yacoub M
Am J Pathol; 1997 Jul; 151(1):111-20. PubMed ID: 9212737
[TBL] [Abstract][Full Text] [Related]
18. Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.
Cooper DK; Good AH; Ye Y; Koren E; Oriol R; Ippolito RM; Malcolm AJ; Neethling FA; Romano E; Zuhdi N
Transplant Proc; 1993 Feb; 25(1 Pt 1):377-8. PubMed ID: 8438342
[No Abstract] [Full Text] [Related]
19. Xenogeneic ex vivo hemoperfusion of rhesus monkey livers with human blood.
Pöhlein C; Lemmens P; Schön MR; Neuhaus P; Thiery J; Hammer C
Transplant Proc; 1994 Jun; 26(3):1061-2. PubMed ID: 8029831
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
Banz Y; Cung T; Korchagina EY; Bovin NV; Haeberli A; Rieben R
Xenotransplantation; 2005 Nov; 12(6):434-43. PubMed ID: 16202066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
